Hoh H B, Hurley C, Claoue C, Viswalingham M, Easty D L, Goldschmidt P, Collum L M
Bristol Eye Hospital.
Br J Ophthalmol. 1996 Feb;80(2):140-3. doi: 10.1136/bjo.80.2.140.
This study was designed to assess the relative efficacy of topical ganciclovir 0.15% gel and acyclovir 3% ointment in the treatment of herpes simplex dendritic keratitis.
Both treatment modalities were administered on a five times daily basis to patients suffering from herpes simplex keratitis. Patients were assigned randomly to one of the two treatment groups for the purpose of the trial. They were then examined on days 2, 7, 10, and 14 to assess the rate of healing of the dendritic ulceration.
There was no statistically significant difference detected in the rate of healing between the two treatment groups over the course of the trial.
Review of the relative efficacy of topical ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis showed that both treatment modalities were equally effective in their ability to heal the viral induced corneal ulceration. There were no significant side effects or adverse effects reported for either treatment modality.
本研究旨在评估0.15%更昔洛韦凝胶和3%阿昔洛韦软膏局部治疗单纯疱疹性树枝状角膜炎的相对疗效。
两种治疗方式均每日5次给予单纯疱疹性角膜炎患者。为进行试验,患者被随机分配至两个治疗组之一。然后在第2、7、10和14天对他们进行检查,以评估树枝状溃疡的愈合速度。
在试验过程中,两个治疗组之间的愈合速度没有检测到统计学上的显著差异。
对局部使用更昔洛韦和阿昔洛韦治疗单纯疱疹性树枝状角膜炎的相对疗效进行回顾表明,两种治疗方式在治愈病毒引起的角膜溃疡方面同样有效。两种治疗方式均未报告有显著的副作用或不良反应。